Home › Funds › Sofinnova Investments, Inc. › MIRM
Sofinnova Investments, Inc. position in MIRM
MIRUM PHARMACEUTICALS INC · Health Care
Sofinnova Investments, Inc. reported holding 27,591 shares of MIRM (MIRUM PHARMACEUTICALS INC) in its Q2 2026 13F filing — a position valued at US$3.2M, representing 0.17% of its reported portfolio and ranking #43 among its reported holdings. Sofinnova Investments, Inc. has disclosed MIRM holdings in 6 of the last 12 reported quarters, going back to Q3 2023.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Sofinnova Investments, Inc.'s MIRM position evolved
Sofinnova Investments, Inc. first disclosed a stake in MIRM in Q3 2023 at 9,089 shares (US$287K). The position peaked in Q4 2023 at 352,397 shares, worth US$10.4M. Across 6 filings, Sofinnova Investments, Inc. increased the stake 2 time(s), trimmed it 1 time(s) and left it unchanged 1 time(s). The most recent filing (Q2 2026) shows 27,591 shares valued at US$3.2M. Notable position changes include a 3777% increase in Q4 2023 (shares fell 15% over the following quarter), a 99% trim in Q1 2024 (shares rose 36% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 9.09K | $287.21K | New |
| Q4 2023 | 352.40K | $10.40M | Add |
| Q1 2024 | 3.01K | $75.66K | Reduce |
| Q4 2025 | 23.10K | $1.82M | New |
| Q1 2026 | 27.59K | $2.55M | Add |
| Q2 2026 | 27.59K | $3.23M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About MIRM and 13F data
MIRM (MIRUM PHARMACEUTICALS INC) is a Health Care company. 62 other funds we track also report a position in MIRM — the largest reported positions include Frazier Life Sciences Management, L.P. (US$899.1M), EVENTIDE ASSET MANAGEMENT, LLC (US$146.2M), TANG CAPITAL MANAGEMENT LLC (US$144.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding MIRM
- Frazier Life Sciences Management, L.P. 7.68M sh · $899.06M · Q2 2026
- EVENTIDE ASSET MANAGEMENT, LLC 1.25M sh · $146.20M · Q2 2026
- TANG CAPITAL MANAGEMENT LLC 1.24M sh · $144.70M · Q2 2026
- Novo Holdings A/S 1.12M sh · $131.70M · Q2 2026
- TCG Crossover Management, LLC 1.06M sh · $124.33M · Q2 2026
- BVF INC/IL 1.06M sh · $123.63M · Q2 2026
- Rock Springs Capital Management LP 798.14K sh · $93.44M · Q2 2026
- TENOR CAPITAL MANAGEMENT Co., L.P. 24.65M sh · $91.66M · Q2 2026
- CAPSTONE INVESTMENT ADVISORS, LLC 18.45M sh · $68.30M · Q2 2026
- EMERALD ADVISERS, LLC 468.30K sh · $54.82M · Q2 2026
- BAKER BROS. ADVISORS LP 445.98K sh · $52.21M · Q2 2026
- NEXT CENTURY GROWTH INVESTORS LLC 420.21K sh · $49.19M · Q2 2026
More on Sofinnova Investments, Inc.
FAQ
How long has Sofinnova Investments, Inc. held MIRM?
Sofinnova Investments, Inc. has disclosed MIRM holdings in 6 of the last 12 reported quarters, going back to Q3 2023.
What is Sofinnova Investments, Inc.'s current position in MIRM?
As of Q2 2026, Sofinnova Investments, Inc. holds 27.59K shares of MIRM (MIRUM PHARMACEUTICALS INC), valued at $3.23M, representing 0.17% of its reported portfolio and ranking #43.
Has Sofinnova Investments, Inc. been buying or selling MIRM?
In the latest 13F filing (Q2 2026), Sofinnova Investments, Inc. held unchanged its position in MIRM. The position peaked in Q4 2023 at 352.40K shares.
Which other funds hold MIRM?
Other major institutional holders of MIRM include Frazier Life Sciences Management, L.P., EVENTIDE ASSET MANAGEMENT, LLC, TANG CAPITAL MANAGEMENT LLC, among 62 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.